Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ.

Br J Cancer. 2012 Aug 7;107(4):695-9. doi: 10.1038/bjc.2012.292.

2.

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.

Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O'Reilly DS, Foulis AK, Horgan PG, McMillan DC.

Eur J Cancer. 2011 Nov;47(17):2633-41. doi: 10.1016/j.ejca.2011.03.028.

PMID:
21724383
3.

Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.

Deng Q, He B, Liu X, Yue J, Ying H, Pan Y, Sun H, Chen J, Wang F, Gao T, Zhang L, Wang S.

J Transl Med. 2015 Feb 18;13:66. doi: 10.1186/s12967-015-0409-0.

4.

A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer.

Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, Hirakawa K.

Anticancer Res. 2013 Aug;33(8):3291-4.

PMID:
23898094
5.

Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

Dirican A, Kucukzeybek BB, Alacacioglu A, Kucukzeybek Y, Erten C, Varol U, Somali I, Demir L, Bayoglu IV, Yildiz Y, Akyol M, Koyuncu B, Coban E, Ulger E, Unay FC, Tarhan MO.

Int J Clin Oncol. 2015 Feb;20(1):70-81. doi: 10.1007/s10147-014-0672-8.

PMID:
24532163
6.

Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.

Dalpiaz O, Pichler M, Mannweiler S, Martín Hernández JM, Stojakovic T, Pummer K, Zigeuner R, Hutterer GC.

Br J Cancer. 2014 May 13;110(10):2531-6. doi: 10.1038/bjc.2014.180.

7.

Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?

Chiang SF, Hung HY, Tang R, Changchien CR, Chen JS, You YT, Chiang JM, Lin JR.

Int J Colorectal Dis. 2012 Oct;27(10):1347-57.

PMID:
22460305
8.
9.

A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.

Zhou D, Zhang Y, Xu L, Zhou Z, Huang J, Chen M.

Sci Rep. 2015 Oct 21;5:15263. doi: 10.1038/srep15263.

10.

A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery.

Malietzis G, Giacometti M, Askari A, Nachiappan S, Kennedy RH, Faiz OD, Aziz O, Jenkins JT.

Ann Surg. 2014 Aug;260(2):287-92. doi: 10.1097/SLA.0000000000000216.

PMID:
24096764
11.

Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study.

Grenader T, Nash S, Adams R, Kaplan R, Fisher D, Maughan T, Bridgewater J.

Br J Cancer. 2016 Mar 15;114(6):612-5. doi: 10.1038/bjc.2016.23.

PMID:
26889974
12.
13.

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.

Absenger G, Szkandera J, Pichler M, Stotz M, Arminger F, Weissmueller M, Schaberl-Moser R, Samonigg H, Stojakovic T, Gerger A.

Br J Cancer. 2013 Jul 23;109(2):395-400. doi: 10.1038/bjc.2013.346.

14.

Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.

Neal CP, Cairns V, Jones MJ, Masood MM, Nana GR, Mann CD, Garcea G, Dennison AR.

Med Oncol. 2015 May;32(5):144. doi: 10.1007/s12032-015-0590-2.

PMID:
25807934
15.

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.

Chua W, Charles KA, Baracos VE, Clarke SJ.

Br J Cancer. 2011 Apr 12;104(8):1288-95. doi: 10.1038/bjc.2011.100.

16.

The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.

Szkandera J, Gerger A, Liegl-Atzwanger B, Stotz M, Samonigg H, Friesenbichler J, Stojakovic T, Leithner A, Pichler M.

Am J Surg. 2015 Jul;210(1):111-6. doi: 10.1016/j.amjsurg.2014.10.021.

PMID:
25586599
17.

Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer.

Guthrie GJ, Roxburgh CS, Farhan-Alanie OM, Horgan PG, McMillan DC.

Br J Cancer. 2013 Jul 9;109(1):24-8. doi: 10.1038/bjc.2013.330.

18.

Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Park JJ, Jang HJ, Oh IY, Yoon CH, Suh JW, Cho YS, Youn TJ, Cho GY, Chae IH, Choi DJ.

Am J Cardiol. 2013 Mar 1;111(5):636-42. doi: 10.1016/j.amjcard.2012.11.012.

PMID:
23273716
19.
20.

An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia.

Spark JI, Sarveswaran J, Blest N, Charalabidis P, Asthana S.

J Vasc Surg. 2010 Sep;52(3):632-6. doi: 10.1016/j.jvs.2010.03.067.

Items per page

Supplemental Content

Support Center